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Tamm-Horsfall protein knockout mice are more prone to uri-
nary tract infection.
Background. Human colon contains many bacteria that com-
monly colonize the perineum and frequently enter the uri-
nary tract. Uropathogenic Escherichia coli are the most com-
mon cause of urinary tract infection. Type 1 fimbriated E. coli
have been associated with cystitis, and P fimbriated E. coli with
pyelonephritis. Factors involved in clearing bacteria from the
urinary tract are poorly understood. Tamm-Horsfall protein
(THP), the most abundant protein in mammalian urine, has
been postulated to play a role in defense against urinary tract
infection but definitive proof for this idea has been lacking.
Methods. In this study, we generated THP gene knockout
mice by the technique of homologous recombination, and ex-
amined if the THP-deficient (THP−/−) mice were more prone to
urinary tract infection. Various strains of E. coli expressing type
1 or P fimbriae were introduced transurethrally into the blad-
ders of the THP−/− and genetically similar wild-type (THP+/+)
mice. Urine, bladder, and kidney tissues were obtained from the
mice and cultured for bacterial growth.
Results. THP−/− mice inoculated with type 1 fimbriated E.
coli had a longer duration of bacteriuria, and more intense col-
onization of the urinary bladder in comparison with THP+/+
mice. When inoculated with a P fimbriated strain of E. coli,
the THP−/− mice showed no difference in kidney bacterial load
when compared with the THP+/+ mice.
Conclusion. These findings support the idea that THP serves
as a soluble receptor for type 1 fimbriated E. coli and helps
eliminate bacteria from the urinary tract.
Urinary tract infections are common, especially in
women [1]. Most urinary tract infections are caused by
bacteria that normally reside in the colon, commonly col-
onize the perineal region, and frequently enter the adja-
cent urethra [2]. Escherichia coli account for 85% of all
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urinary tract infections [1, 3]. The uropathogenicity of E.
coli is critically dependent on filamentous appendages
on the bacterial surface, called pili or fimbriae. A
number of fimbrial types, including type 1, P, S, and Dr
adhesions, have been described [3]. Among these type 1
fimbriae have been found to be associated with cystitis,
and P fimbriae with pyelonephritis. It is postulated that
urine contains host defense factors that continually clear
the urinary tract of contaminating bacteria. Currently,
these defense mechanisms are not understood fully [3,
4]. Tamm-Horsfall protein (THP) is the most abundant
protein in normal urine [5–9]. THP is a polymeric glyco-
protein with a monomeric molecular weight of 90,000 Da.
It is richly decorated with the most varied array of
N-linked, complex type, oligosaccharides found in any
human glycoprotein [10]. In addition, some high-
mannose [11], and O-linked residues [12] are also present.
THP is conserved in evolution [13], and synthesized only
in the kidney [14]. The normal physiological function of
THP has remained elusive despite extensive study. The
biochemical properties of THP and its abundant presence
in urine make it a candidate for being a host defense fac-
tor that might be involved in clearing bacteria from the
urinary tract. Indeed, in vitro studies have shown the abil-
ity of THP to bind E. coli [15–18], bacteria that commonly
cause urinary tract infaction.
In this study, we examined the role of THP as a host
defense mechanism against urinary tract infection by cre-
ating a mouse deficient in THP by the technique of gene
targeting [19], and by determining if the THP-deficient
(THP−/−) mouse had difficulty clearing bacteria intro-
duced into its bladder.
METHODS
Generation of THP knockout mice
Human THP cDNA probes [14] were used to isolate
mouse THP cDNA [20] that was used to probe a mouse
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129/sv liver k Fix II genomic library (Stratagene, LaJolla,
CA, USA) to obtain the full-length mouse THP gene.
The THP gene was characterized by restriction analy-
sis, partial sequencing, and comparison with human and
rat gene restriction maps [21]. An omega-type replace-
ment targeting vector [22] was constructed incorporating
a 2 kb segment 5′ of the cap site of the THP gene and
the first four exons plus the intervening introns of the
THP gene (Fig. 1A). The linearized vector was electro-
porated into embryonic stem cells, obtained from mouse
strain 129/sv (brown coat). Successfully transfected em-
bryonal stem cells were injected into developing blasto-
cysts from C57Bl/6 (black coat) mice to obtain chimeric
mice. Chimeric mice were bred with Black Swiss female
mice and screened by polymerase chain reaction (PCR)
of tail DNA to obtain mice heterozygous for THP defi-
ciency. The heterozygous mice were bred with each other
to obtain THP+/+ and THP−/− offspring. The absence of
THP was confirmed by Northern blot (Fig. 1B), Western
blot (Fig. 1C), and by immunocytochemistry (Fig. 1D).
The THP mutation was also backcrossed onto the
129/sv strain for seven generations to produce THP+/+
and THP−/− offspring with a similar genetic background.
The THP−/− mice revealed no gross anomalies. They
grew and bred normally. Serum electrolytes, urinalysis,
and kidney histology was normal. There was no evidence
of pyelonephritis.
Northern blot of mouse kidney for THP RNA
Total RNA was isolated from mouse kidneys by a
commercial reagent based on the original method of
Chomczynski and Sacchi (TRIzol) (Life Technologies,
Rockville, MD, USA) [23]. Fifteen micrograms of total
RNA was electrophoresed on a 1% agarose gel con-
taining 2.2 mol/L formaldehyde and 0.02 mol/L 3-(N-
morpholino)-propanesulfonic acid (MOPS), pH 7.0, and
1 mmol/L ethylenediaminetetraacetic acid (EDTA). Af-
ter washing the gel several times in diethylpyrocarbonate
(DEPC)-treated water, the RNA was transferred with
10 × standard sodium citrate (SSC) (1.5 mol/L NaCl,
0.15 mol/L sodium citrate) by capillary transfer to a ny-
lon membrane (GeneScreen Plus) (NEN, Boston, MA,
USA). A mouse cDNA probe was labeled with [a-32
P] deoxycytidine triphosphate (dCTP) (3000 Ci/mmol)
(ICN, Irvine, CA, USA) with random prime method
(Oligo Labelling Kit) (Pharmacia LKB Biotechnology,
Piscataway, NJ, USA). The blot was hybridized overnight
at 68◦C in Church’s buffer containing 7% sodium do-
decyl sulfate (SDS), 1% bovine serum albumin (BSA),
0.5 mol/L NaHPO4, pH 7.2, and 1 mmol/L EDTA. The
blot was washed twice for 30 minutes with a solution con-
taining 0.04 mol/L NaHPO4, 5% SDS, 0.5% BSA, and
1 mmol/L EDTA and twice for 30 minutes with a solution
of 0.04 mol/L NaHPO4, 1% SDS, and 1 mmol/L EDTA
at 68◦C. Autoradiography of the blot was performed for
6 hours at –80◦C using BioMax MS film and a Transcreen
HE intensifying screen (Eastman Kodak, Rochester, NY,
USA).
Western blot of mouse kidney for THP
After carbon dioxide narcosis, kidneys were removed
from THP wild-type (+/+), heterozygous (+/−), and
null (−/−) mice. Each kidney was homogenized with a
glass homogenizer at 4◦C in 1 mL of lysis buffer con-
taining 25 mmol/L Tris-HCl, pH6.8, 10 lg/mL apro-
tinin, 10 lg/mL leupeptin, 1 lg/mL pepstatin, 100 lg/mL
phenylmethylsulfonyl fluoride (PMSF), and 2 mmol/L
EDTA. The homogenates were centrifuged at 5000 ×
g for 20 minutes at 4◦C. The supernatants (after fil-
tration through cheesecloth to remove fat) were as-
sayed for total protein with a kit (BCA Protein Assay
Kit) (Pierce, Rockford, IL, USA). Samples containing
5 lg of total protein were solubilized in Laemmli buffer
containing b-mercaptoethanol and electrophoresed on
a 10% SDS-polyacrylamide minigel (Mini-Protean II)
(Bio-Rad, Hercules, CA, USA). The proteins were elec-
trophoretically transferred to a nitrocellulose membrane
(Nitro Plus, MSI, Westboro, MA, USA). After blocking
overnight with 5% nonfat milk in phosphate buffered
saline (PBS) at 4◦C, the blot was probed with a rab-
bit antihuman THP antibody (50 lg/mL in PBS) (BTI,
Stroughton, MA,USA). The blot was washed three times
with PBS/0.05% Tween-20, and probed with a goat an-
tirabbit IgG conjugated with horseradish peroxidase
(1:5000) (Sigma Chemical Co., St. Louis, MO, USA).
The blot was again washed three times with PBS/0.05%
Tween-20. The blotted proteins were detected with a
chemiluminescent agent (ECL) (Amersham, Arlington
Heights, IL, USA), using BioMax MS film (Eastman
Kodak Co.).
Immunohistochemical staining of mouse kidney for THP
Kidneys from THP+/+ and THP−/− mice were sec-
tioned sagittally and fixed in 10% buffered formalin. The
kidneys were embedded in paraffin and eight micron sec-
tions prepared. After deparaffinization in xylene and re-
hydration through a graded ethanol series and water, the
slides were washed in PBS. Endogenous peroxidase was
inhibited by incubating the slides for 20 minutes in 0.3%
hydrogen peroxide in methanol. After washing in PBS for
20 minutes, nonspecific binding was blocked for 20 min-
utes with 2% goat serum (Vectastain ABC Kit) (Vector
Labs, Burlingame, CA, USA). A rabbit antihuman THP
antibody (BTI) diluted 1:3000 in PBS/0.1% BSA was
applied to the sections and incubated overnight at 4◦C
in a humidity chamber. The slides were washed in PBS
(10 minutes, twice) and incubated with a secondary bi-
otinylated antibody (goat anti rabbit IgG, Vectastain
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Fig. 1. Strategy for targeted disruption of the mouse Tamm-Horsfall protein (THP) gene and confirmation of the absence of THP in THP gene
knockout mice. (A) 1, The THP genomic locus consisted of a 6.3 kb Not I (N)-BstXI (B) fragment of the 5′ end of the mouse THP gene which
includes exons 0, 1, 2, and 3. 2, The targeting vector consisted of a 2.9 kb Xho I (X)-Not I (N) fragment of a DNA fragment containing the thymidine
kinase gene (Tk) that acts as a negative selection marker for random recombinants, a 5.5 kb Not I (N)-Kpn I (K) fragment of the mouse THP gene,
an 0.9 kb Kpn I (K)-BstXI (B, converted to a Cla I site) fragment of the mouse THP gene with a 1.6 kb DNA fragment containing the neomycin
phosphotransferase gene (Neo) that acts as a positive selection marker for correctly targeted clones, inserted into the Xho I site in exon 2, and a
3 kb Cla I-Xho I fragment of the pGEM7f plasmid (vector). 3, The targeted allele with the “Neo,” positive selection cassette, disrupting exon 2 of
the mouse THP gene. (B) Northern blot of kidney RNA from wild type (+/+), heterozygous (+/−) and null (−/−) mice. (C) Western blot of total
kidney protein from wild type (+/+), heterozygous (+/−) and null (−/−) mice. (D) Immunohistochemical staining of kidney sections from wild
type (+/+) and null (−/−) mice.
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ABC Kit) at a dilution of 1:200 in PBS/0.1% BSA for
90 minutes at room temperature. The slides were washed
in PBS (10 minutes, twice) and the ABC reagent (Vectas-
tain ABC Kit) (Vector Labs) was applied for 30 minutes
at room temperature. After washing with PBS, the slides
were incubated with a 3,3-diamino benzidine (DAB) so-
lution until brown color developed (monitored through
microscope). After placing in tap water, the slides were
counterstained with hematoxylin and mounted under
cover slips.
Bacterial preparations
E. coli strain J96 (ATCC 700336), a pyelonephritis
isolate with capacity to express both type 1 and P fim-
briae under specific culture conditions, was obtained from
the American Type Culture Collection (ATCC, Manas-
sas, VA, USA) and propagated in tryptose broth. An
overnight, stationary phase, tryptose broth culture was
made from the main culture, and bacteria harvested from
the air-broth interface to select for bacteria expressing
type 1 fimbriae. The number of bacteria/mL was deter-
mined spectrophotometrically at 600 nm. The bacterial
suspension was centrifuged at 3600 rpm for 20 minutes,
and the pellet washed twice with PBS. A final suspension
was made in PBS at 1 × 1012 bacteria/mL. E. coli strain
UTI89, a clinical cystitis strain mainly expressing type 1
fimbriae, was propagated as above and suspended in PBS
at 4 × 107 bacteria/mL. E. coli strain AAEC185/pSH2,
a recombinant strain with full type 1 pilus operon, ex-
pressing only type 1 fimbriae [24], was propagated in
tryptose broth with chloramphenicol, centrifuged, and re-
suspended in PBS at 4 × 1011 bacteria/mL. E. coli strain
DS17, a pyelonephritis isolate expressing mainly P fim-
briae, was propagated in Luria-Bertani (LB) medium,
centrifuged, and resuspended in PBS at 1 × 1011
bacteria/mL.
Animal experimental procedures
Bacteriuria studies. THP+/+ and THP−/− female
mice were kept in separate mouse cages and allowed
to eat and drink ad libitum. The perineum was cleaned
with 70% isopropanol. Gentle pressure was applied to
the suprapubic region of the mouse, and the urine drops
appearing at the urethral meatus aspirated with a ster-
ile pipet. Baseline urine specimens were obtained and
cultured on Eosin Methylene Blue (EMB) agar (Becton
Dickinson, Sparks, MD, USA) at 37◦C overnight to ex-
clude preexisting infection. A few mice were excluded
from experiments due to preexisting infection. Sponta-
neous urinary tract infections were rare and did not oc-
cur more frequently in the THP−/− mice in comparison
with THP+/+ mice. The mice were deprived of water for
4 hours and anesthetized with xylazine (Butler, Colum-
bus, OH, USA), 8mg/kg, and ketamine (Fort Dodge An-
imal Health, Fort Dodge, IA, USA), 120 mg/kg. Preexist-
ing urine was removed from the bladder by gentle squeez-
ing before inoculation. Under aseptic conditions, 10 lL
of a 1 × 1012 bacteria/mL suspension of E. coli strain
J96 was introduced into the bladder transurethrally us-
ing a 50 lL syringe (Hamilton, Reno, NV, USA) fitted
with a 28 G needle and polyethylene tubing with an in-
ner diameter of 0.28 mm and outer diameter of 0.61 mm
(Becton Dickinson). The mice were allowed to recover
from anesthesia and allowed free access to food and wa-
ter. In experiments with E. coli strain UTI89, 25 lL of a
4 × 107 bacteria/mL suspension was introduced into the
bladder and the catheter clamped. After 1 hour, the clamp
was released and the catheter removed. In experiments
with E. coli strain AAEC185/pSH2, 25 lL of a 4 × 1011
bacteria/mL suspension was introduced transurethrally
using the same methods as for UTI89. For bacteriuria
studies, mouse urine was collected aseptically at 1, 3, 5,
and 7 days post-inoculation and weekly thereafter, until
the urine cultures became negative. The urine specimens
were serially diluted and cultured on EMB agar overnight
at 37◦C. Colony forming units (CFU) were counted the
next day and the number of E. coli/mL of urine was cal-
culated and expressed as CFU/mL of urine.
Bladder colonization studies. A suspension of E. coli
strain J96 was introduced into mouse bladders as above.
Mice were euthanized 24 hours after transurethral in-
oculation of E. coli, using carbon dioxide narcosis. The
urine was expressed from the bladder prior to euthana-
sia. The bladders were removed aseptically and bisected.
Half of each bladder was weighed and homogenized sep-
arately using glass tissue grinders (Kontes, Vineland, NJ,
USA). The homogenates were serially diluted in PBS and
cultured on EMB agar. On the next day the CFUs on
each EMB plate were counted and expressed as CFU/mg
bladder tissue. The other half of each bladder was pro-
cessed for histopathologic examination. Bladder tissue
specimens were fixed overnight in 10% neutral buffered
formalin. Sections of 5 lm thickness were cut from
paraffin-embedded tissue and stained with hematoxylin
and eosin. The slides were examined by light microscopy
by a pathologist.
Kidney colonization studies. In experiments with
E. coli strain DS17, a pyelonephritis isolate expressing
mainly P fimbriae, 100 lL of a 1 × 1011 bacteria/mL sus-
pension was inoculated into mice transurethrally using
a 100 lL syringe (Hamilton) fitted with a 28 G needle
and polyethylene tubing. The catheter attached to the sy-
ringe was allowed to remain in the urethra for 1 hour.
Mice were euthanized 5 days after transurethral inocula-
tion of E. coli, using carbon dioxide narcosis. The urine
was expressed from the bladder prior to euthanasia. The
kidneys were removed aseptically, weighed and homoge-
nized separately using glass tissue grinders (Kontes). The
homogenates were serially diluted in PBS and cultured
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Table 1. Bacteria/mL of urine in Tamm-Horsfall protein (THP)+/+ and THP−/− mice after inoculation of Escherichia coli strain J96
Day-3 Day-5 Day-14
Experiment
Number THP+/+ THP−/− THP+/+ THP−/− THP+/+ THP−/−
1 0 1.4 × 104 0 0 0 0
2 0 2 × 103 0 0 0 0
3 1 × 103 >1012 0 1.1 × 1010 0 Died
4 8.8 × 102 8.1 × 1010 6.4 × 102 0.3 × 1010 0 Died
5 0 8 × 102 0 0 0 0
6 0 2.2 × 103 0 0 0 0
7 7.4 × 102 4.5 × 104 0 1 × 102 0 0
on EMB agar. On the next day the CFUs on each EMB
plate were counted and expressed as CFU/mg kidney
tissue.
The animal experiments were pre approved by the In-
stitutional Animal Care and Use Committee (IACUC)
of the University of Oklahoma Health Sciences Center.
Statistical analysis
Data are expressed as means ± SE. Student t test was
used for comparison of groups using the SPSS statisti-
cal program (SPSS, Inc., Chicago, IL, USA). Statistical
significance was set at P < 0.05.
RESULTS
Bacteriuria studies
Results from seven separate bacteriuria experiments
are shown in Table 1. In each experiment with E. coli
strain J96, the THP−/− mouse cleared the bacteria from
urine slower than the THP+/+ mouse. On day 3, urine
from four out of seven THP+/+ mice was clear of bacte-
ria, while seven out of seven THP−/− mice showed bac-
teriuria. On day 5, six out of seven THP+/+ mice had
cleared the bacteria from the urine while three out of
seven THP−/− continued to excrete bacteria. By day 14,
all THP+/+ mice had cleared the bacteria from urine,
while five out of seven THP−/− mice had cleared the bac-
teria from urine. Two out of seven THP−/− mice died by
day 14, and their kidneys showed severe pyelonephritis
and micro-abscesses in the kidney.
Similar experiments were performed with E. coli
strains UTI89 and AAEC185/pSH2. In studies with E.
coli strain UTI89 (Fig. 2A), the THP−/− mice had more
severe bacteriuria at 24 hours post-inoculation (mean
log10 CFU/mL + 1, 6.84 ± 0.32) compared to the THP+/+
mice (mean log10 CFU/mL + 1, 3.70 ± 0.91; P =
0.004). Experiments with E. coli strain AAEC185/pSH2
(Fig. 2B) also showed a greater number of E. coli/mL
of urine at 24 hours post-inoculation in THP−/− mice
(mean log10 CFU/mL 5.6 ± 0.43) compared to THP+/+



































Fig. 2. Distribution of colony forming units (CFU)/mL of urine
24 hours after transurethral inoculation of Escherichia coli. (A) UTI89
(expressed as the log10 CFU/mL + 1) in wild-type (+/+) and null (−/−)
mice. (B) AAEC185/pSH2 (expressed as the log10 CFU/mL) in wild-
type (+/+) and null (−/−) mice.


















Fig. 3. Bacterial colonies isolated from homogenized bladder tissue
24 hours after transurethral inoculation of Escherichia coli strain J96.
(A) The Eosin Methylene Blue agar plates show bacterial colonies iso-
lated from homogenized bladder tissue of wild type (+/+) and null
(−/−) mice 24 hours after transurethral inoculation with E. coli J96.
(B) Comparison of colony forming units (CFU)/mg of bladder tissue
(expressed as log10 CFU/mg tissue) 24 hours after transurethral inocu-
lation of wild type (+/+) and null (−/−) mice with E. coli J96.
Bladder colonization studies
Bladder tissue homogenates were cultured after
transurethral inoculation of E. coli strain J96 and bac-
terial load/mg of tissue demonstrated that THP−/− mice
had more severe colonization than THP+/+ mice (mean
log10 CFU/mg 5.07 ± 0.38 in THP−/− mice versus mean
log10 CFU/mg 3.15 ± 0.45 in THP+/+ mice, P = 0.01)
in five consecutive experiments (Fig. 3). Bladder tissues
were examined for histologic changes and there were
no differences in THP+/+ and THP−/− mice bladders at
24 hours after inoculation.
Kidney colonization studies
Kidney tissue homogenates were cultured 5 days af-
ter transurethral inoculation of the P fimbriated E. coli

















Fig. 4. Distribution of colony forming units (CFU)/mg of kidney tissue
5 days after transurethral inoculation of Escherichia coli DS 17 (ex-
pressed as the log10 CFU/mg +1) in wild-type (+/+) and null (−/−)
mice.
significant difference between the THP−/− mice and the
THP+/+ mice in six experiments (Fig. 4).
DISCUSSION
The biologic function of THP (also known as uromu-
coid [25] or uromodulin [26]) has been speculated upon
since 1895. Several physiologic and pathologic roles have
been postulated for THP such as ion transport in kidney
tubules, renal excretion of cytokines, and the pathogen-
esis of kidney stones, and of acute renal failure. Its exact
biologic function, however, has remained unclear [3–6].
Orskov, Orskov, and Birch-Anderson [15] and Orskov,
Ferencz, and Orskov [16] first reported that THP in so-
lution could bind E. coli, and that this binding was in-
hibited by D-mannose. Subsequently, THP was shown to
bind bacteria on solid surfaces [17, 18] and to the surface
of bacteria by electron microscopy [27]. THP has also
been shown to inhibit binding of bacteria to human kid-
ney cells in tissue culture [28] and to synthetic analogues
of urothelial surface receptors [29]. The biologic signif-
icance of these in vitro findings, however, has remained
unclear thus far. Our data provide new, in vivo, evidence
that interactions between THP and E. coli are likely to
be biologically important.
E. coli are the most common cause of urinary tract in-
fection. Binding of E. coli to the urothelium is critically
dependent upon the type of fimbriae present on the bacte-
rial cell surface. Type 1 fimbriae bind mannose residues on
the cell surface and P fimbriae bind a globoside that con-
sists of the tetrasaccharide GalNAcb1–3Gala1–4Galb1–
4Glc linked to ceramide [30]. In this study, we found that
THP−/− mice are more prone to infection by type 1 but
not P fimbriated E. coli. This finding is consistent with the
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fact that THP contains high mannose structures among
its oligosaccharides but not the ligand for P fimbriae. The
function of the diverse array of complex type carbohy-
drate structures on the surface of THP remains uncer-
tain at this time. It is likely that they serve as binding
sites for other substances that need to be cleared from
the urine such as cells, cytokines, crystals, ions, and other
microorganisms.
Overall, these data provide the first direct in vivo evi-
dence that THP serves a role in continually clearing the
urine of contaminating bacteria. Not only do these find-
ings identify a novel host defense mechanism against uri-
nary tract infection, they also assign an important biologic
function to urine’s most abundant protein.
Recently, point mutations in the human THP gene have
been shown to be associated with medullary cystic dis-
ease of kidneys [31]. No cysts or fibrosis were observed
in THP−/− mice in our experiments up to 24 months.
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